Literature DB >> 3418783

Influenza virus regulates protein synthesis during infection by repressing autophosphorylation and activity of the cellular 68,000-Mr protein kinase.

M G Katze1, J Tomita, T Black, R M Krug, B Safer, A Hovanessian.   

Abstract

We investigated the mechanisms by which influenza virus prevents shutoff of protein synthesis by a cellular protein kinase normally activated during infection. Earlier work has shown that influenza virus superinfection of cells previously infected by the adenovirus VAI RNA-negative mutant dl331 resulted in selective translation of influenza virus mRNAs and suppression of the elevated protein kinase levels normally found in cells infected by the mutant alone (M. G. Katze, B. M. Detjen, B. Safer, and R. M. Krug, Mol. Cell. Biol. 6:1741-1750, 1986). We elucidated the mechanisms of this kinase repression and can now report that influenza virus encodes a gene product which functions to directly block the autophosphorylation and activity of the interferon-induced, double-stranded-RNA-activated protein kinase, P68. Suppressed P68 activity was found not only in doubly infected cells but also in cells infected by influenza virus alone. Moreover, the decrease in P68 activity correlated with a decrease in the endogenous levels of phosphorylation of the alpha subunit of the eucaryotic initiation factor eIF-2, the natural substrate of the protein kinase. Suppression of P68 activity occurred as early as 2 h after influenza virus infection and required viral gene expression beyond the level of primary mRNA transcription to take place. We confirmed our in vivo observations with in vitro mixing experiments which showed that the influenza virus inhibitor can act in trans to block P68 activity. Combined repression of P68 function and eIF-2 alpha phosphorylation during influenza virus infection is essential for continued catalytic recycling of eIF-2 and efficient mRNA translation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3418783      PMCID: PMC253514          DOI: 10.1128/JVI.62.10.3710-3717.1988

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Purification of influenza viral complementary RNA: its genetic content and activity in wheat germ cell-free extracts.

Authors:  P R Etkind; R M Krug
Journal:  J Virol       Date:  1975-12       Impact factor: 5.103

2.  Characteristics of a human cell line transformed by DNA from human adenovirus type 5.

Authors:  F L Graham; J Smiley; W C Russell; R Nairn
Journal:  J Gen Virol       Date:  1977-07       Impact factor: 3.891

3.  Intracellular uncoating of type 5 adenovirus deoxyribonucleic acid.

Authors:  W C Lawrence; H S Ginsberg
Journal:  J Virol       Date:  1967-10       Impact factor: 5.103

Review 4.  The regulation of initiation of mammalian protein synthesis.

Authors:  R Jagus; W F Anderson; B Safer
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1981

Review 5.  Biochemistry of interferons and their actions.

Authors:  P Lengyel
Journal:  Annu Rev Biochem       Date:  1982       Impact factor: 23.643

Review 6.  Inborn resistance of ice to orthomyxoviruses.

Authors:  O Haller
Journal:  Curr Top Microbiol Immunol       Date:  1981       Impact factor: 4.291

7.  Purification of the eukaryotic initiation factor 2-eukaryotic initiation factor 2B complex and characterization of its guanine nucleotide exchange activity during protein synthesis initiation.

Authors:  A Konieczny; B Safer
Journal:  J Biol Chem       Date:  1983-03-10       Impact factor: 5.157

8.  Structural requirements of double-stranded RNA for the activation of 2',5'-oligo(A) polymerase and protein kinase of interferon-treated HeLa cells.

Authors:  M A Minks; D K West; S Benvin; C Baglioni
Journal:  J Biol Chem       Date:  1979-10-25       Impact factor: 5.157

9.  Adenovirus VAI RNA is required for efficient translation of viral mRNAs at late times after infection.

Authors:  B Thimmappaya; C Weinberger; R J Schneider; T Shenk
Journal:  Cell       Date:  1982-12       Impact factor: 41.582

10.  Regulation of protein synthesis in vesicular stomatitis virus-infected mouse L-929 cells by decreased protein synthesis initiation factor 2 activity.

Authors:  M Centrella; J Lucas-Lenard
Journal:  J Virol       Date:  1982-03       Impact factor: 5.103

View more
  38 in total

Review 1.  Translational control of viral gene expression in eukaryotes.

Authors:  M Gale; S L Tan; M G Katze
Journal:  Microbiol Mol Biol Rev       Date:  2000-06       Impact factor: 11.056

2.  Protein synthesis shut-off induced by influenza virus infection is independent of PKR activity.

Authors:  T Zürcher; R M Marión; J Ortín
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Molecular signatures associated with Mx1-mediated resistance to highly pathogenic influenza virus infection: mechanisms of survival.

Authors:  Cristian Cilloniz; Mary J Pantin-Jackwood; Chester Ni; Victoria S Carter; Marcus J Korth; David E Swayne; Terrence M Tumpey; Michael G Katze
Journal:  J Virol       Date:  2011-12-21       Impact factor: 5.103

4.  The phosphorylation state of eucaryotic initiation factor 2 alters translational efficiency of specific mRNAs.

Authors:  R J Kaufman; M V Davies; V K Pathak; J W Hershey
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

5.  Purification and partial characterization of a cellular inhibitor of the interferon-induced protein kinase of Mr 68,000 from influenza virus-infected cells.

Authors:  T G Lee; J Tomita; A G Hovanessian; M G Katze
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

6.  Functional expression and RNA binding analysis of the interferon-induced, double-stranded RNA-activated, 68,000-Mr protein kinase in a cell-free system.

Authors:  M G Katze; M Wambach; M L Wong; M Garfinkel; E Meurs; K Chong; B R Williams; A G Hovanessian; G N Barber
Journal:  Mol Cell Biol       Date:  1991-11       Impact factor: 4.272

7.  The 58,000-dalton cellular inhibitor of the interferon-induced double-stranded RNA-activated protein kinase (PKR) is a member of the tetratricopeptide repeat family of proteins.

Authors:  T G Lee; N Tang; S Thompson; J Miller; M G Katze
Journal:  Mol Cell Biol       Date:  1994-04       Impact factor: 4.272

8.  Degradation of the interferon-induced 68,000-M(r) protein kinase by poliovirus requires RNA.

Authors:  T L Black; G N Barber; M G Katze
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

9.  Antiviral effects of geranylgeranylacetone: enhancement of MxA expression and phosphorylation of PKR during influenza virus infection.

Authors:  Masako Unoshima; Hideo Iwasaka; Junko Eto; Yoshiko Takita-Sonoda; Takayuki Noguchi; Akira Nishizono
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

10.  Mutant influenza viruses with a defective NS1 protein cannot block the activation of PKR in infected cells.

Authors:  E Hatada; S Saito; R Fukuda
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.